The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,259.00
Bid: 1,250.00
Ask: 1,258.00
Change: 0.00 (0.00%)
Spread: 8.00 (0.64%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,259.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of SWF Arrangement & Fund Management

26 May 2022 07:00

RNS Number : 8465M
Burford Capital Limited
26 May 2022
 

 

26 May 2022

 

 

BURFORD EXTENDS LIFE OF SOVEREIGN WEALTH FUND ARRANGEMENT

AND COMMENTS ON FUND MANAGEMENT BUSINESS

 

Burford Capital Limited, the leading global finance and asset management firm focused on law, today announces the extension of its arrangement ("BOF-C") with its sovereign wealth fund strategic partner (the "SWF") through December 31, 2023.

 

While BOF-C was nearly full at the end of 2021, with $633 million in active commitments out of its $667 million fund size, only $274 million was deployed. It is our judgment that BOF-C is able to support additional commitments, and we have thus agreed with the SWF to extend the investment period by one year to permit that to occur. If BOF-C reaches the point prior to the expiration of the extended investment period where we regard it as fully committed, we expect to cease allocating new matters to BOF-C. Until that time, we will allocate 25% of each new matter that meets the relevant investment criteria to BOF-C, and the balance sheet will take the remaining 75%. This change from the current 50%/50% allocation permits the balance sheet to take more of each new core legal finance asset in light of Burford's recent incremental capital raise while providing a greater diversity of matters to the SWF.

 

Burford is very pleased with the constructive and ongoing relationship with the SWF, as reflected not only in these changes but also in the SWF's provision of a $100 million sidecar facility during the course of 2021.

 

In light of this amendment to BOF-C and our recent successful $360 million debt offering, it is opportune to comment on our approach to the fund management business more generally, building on the commentary in our management letter included in Burford's 2021 annual report.

 

We think about our business in three broad ranges of potential returns, 20% internal rate of return ("IRR"), and we take a considered approach to balance sheet structure and capital allocation within each range. Of course, these return ranges are anticipated and actual returns may vary.

 

In our lowest range of potential returns,

 

In our middle range of potential returns, 12-20%, we operate through our new fund, the Burford Advantage Fund, in which our balance sheet makes a 20% investment. Again, by making capital available in this range of returns, we provide a service to clients and we expect to operate on a standalone profitable basis, including an attractive return on our capital committed to the Burford Advantage Fund, given the characteristics of the underlying matters and our profit-sharing arrangement with limited partners.

 

The highest range of potential returns, >20%, is our core legal finance business which is characterized by the need for extensive diligence and ongoing case management performed by highly qualified professionals along with assets that do not scale particularly well. Thus, a traditional 2% management fee does not cover our operating costs, and we view a 20% performance fee as inadequate compensation for the approximately 30% IRR we have historically generated. While we will continue to explore alternative structures and fee levels, as illustrated by BOF-C and by our new Burford Advantage Fund, we are disinclined to continue allocating high-return assets to a classic 2&20 private fund and, in light of our recent incremental capital raise, do not plan to raise a successor to the Burford Opportunity Fund at this time but instead allocate more of our future high-return assets to the Burford-only balance sheet and our public shareholders.

 

 

For further information, please contact:

 

Burford Capital Limited

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176

Numis Securities Limited - NOMAD and Joint Broker

+44 (0)20 7260 1000

Giles Rolls

Charlie Farquhar

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

Tony White

 

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR), and it works with companies and law firms around the world from its principal offices in New York, London, Chicago, Washington, DC, Singapore, Sydney and Hong Kong.

 

For more information, please visit www.burfordcapital.com.

 

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC, which acts as the fund manager of all Burford funds, is registered as an investment adviser with the US Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential private placement memorandum and other offering documents.

 

Forward-looking statements

This announcement contains "forward-looking statements" within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, regarding assumptions, expectations, projections, intentions and beliefs about future events. These statements are intended as "forward-looking statements". In some cases, predictive, future-tense or forward-looking words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will" or the negative of such terms or other comparable terminology are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. In addition, we and our representatives may from time to time make other oral or written statements which are forward-looking statements, including in our periodic reports that we file with, or furnish to, the US Securities and Exchange Commission, other information sent to our security holders and other written materials. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and are based on numerous assumptions, expectations, projections, intentions and beliefs and that our actual results of operations, including our financial position and liquidity, and the development of the industry in which we operate, may differ materially from (and be more negative than) those made in, or suggested by, the forward-looking statements contained in this announcement. Significant factors that may cause actual results to differ from those we expect include those discussed under "Risk Factors" in our Annual Report on Form 20-F filed with the US Securities and Exchange Commission on March 29, 2022 and other reports or documents that we file with, or furnish to, the US Securities and Exchange Commission from time to time. In addition, even if our results of operations, including our financial position and liquidity, and the development of the industry in which we operate are consistent with the forward-looking statements contained in this announcement, those results of operations or developments may not be indicative of results or developments in subsequent periods.

 

Except as required by law, we undertake no obligation to update or revise the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBELLLLELEBBL
Date   Source Headline
16th Apr 20243:30 pmRNSHolding(s) in Company
10th Apr 202412:00 pmRNSNotice of Retail Shareholder Call on June 20, 2024
10th Apr 202412:00 pmRNSIssuance of New Shares in Connection With LTIP
10th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholdings & Ownership Update
28th Mar 202411:00 amRNSAvailability of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20244:45 pmRNSNotification of Transactions by PDMRs
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSIntended Purchases of Ordinary Shares
14th Mar 202411:00 amRNSAnnual results for year ended December 31, 2023
7th Mar 20245:30 pmRNSHolding(s) in Company
7th Mar 20242:00 pmRNSNotice of 2023 Results & Results Call Details
30th Jan 20244:15 pmRNSClosing of Private Offering of Senior Notes
18th Jan 202412:00 pmRNSPamela Corrie Appointed as Board Director
17th Jan 20247:00 amRNSPricing and Upsizing of Senior Notes Offering
16th Jan 202412:45 pmRNSPrivate Offering of Senior Notes
3rd Jan 202412:00 pmRNSIssuance of New Shares in Connection with LTIP
22nd Nov 202312:00 pmRNSDirector/PDMR Shareholding
16th Nov 202312:00 pmRNSSterling Conversion Rate for 2023 Interim Dividend
9th Nov 202312:00 pmRNS3Q23 Results & Quarterly Report
3rd Nov 20237:05 amRNSNotice of 3Q23 Results & Results Call Details
9th Oct 202312:00 pmRNSIssuance of New Shares in Connection with LTIP
9th Oct 202311:45 amRNSExpansion and Further Extension of SWF Arrangement
27th Sep 20235:30 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20231:30 pmRNSTransaction in Own Shares
13th Sep 202312:00 pmRNS2Q23 Results & Quarterly Report
11th Sep 20237:00 amRNSStatement on YPF Damages Ruling
8th Sep 20234:30 pmRNSSuspension - Burford Capital Limited
8th Sep 20234:09 pmRNSStatement re Petersen and Eton Park Matters
31st Aug 20232:00 pmRNSNotice of 2Q23 Results Call Details
25th Aug 20237:00 amRNSUS SEC Closes Comment Letter Review
9th Aug 20232:00 pmRNSDirector/PDMR Shareholding
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding
26th Jun 20232:08 pmRNSUpdate & Release Date for 2Q23 Results
26th Jun 20232:07 pmRNSNotice of Early Redemption of Bonds due 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.